bendamustine hydrochloride has been researched along with Carcinoma, Small Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allendorf, DJ; Bordoni, RE; Dixon, PM; Grant, SC; Jerome, ML; Miley, DK; Reddy, VB; Robert, F; Saleh, MN; Singh, KP | 1 |
| Hortig, P; Keilholz, U; Knödler, M; Schmittel, A; Schulze, K; Thiel, E | 1 |
| Gatzemeier, U; Haering, B; Kaukel, E; Koschel, G; Reck, M; von Pawel, J | 1 |
3 trial(s) available for bendamustine hydrochloride and Carcinoma, Small Cell
| Article | Year |
|---|---|
Phase I/IIa study of sequential chemotherapy regimen of bendamustine/irinotecan followed by etoposide/carboplatin in untreated patients with extensive disease small cell lung cancer (EDSCLC).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Biomarkers, Tumor; Brain Diseases, Metabolic; Camptothecin; Carboplatin; Carcinoma, Small Cell; Disease-Free Survival; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Administration Schedule; Endonucleases; Etoposide; Fatigue; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Irinotecan; Kaplan-Meier Estimate; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Mitosis; Multiple Organ Failure; Pneumonia; Treatment Outcome; Weight Loss | 2015 |
Phase II trial of second-line bendamustine chemotherapy in relapsed small cell lung cancer patients.
Topics: Aged; Antineoplastic Agents; Bendamustine Hydrochloride; Carcinoma, Small Cell; Disease-Free Survival; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitrogen Mustard Compounds; Recurrence; Survival Analysis; Time Factors | 2007 |
[Chemotherapy of advanced non-small-cell and small-cell bronchial carcinoma with bendamustine--a phase II study].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Bendamustine Hydrochloride; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Nitrogen Mustard Compounds; Palliative Care; Survival Rate; Treatment Outcome | 1998 |